BDBM3156 2-{[2,6-dihydroxy-4-({[(3S,5R)-2-[(4-hydroxybenzene)amido]-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]oxy}carbonyl)phenyl]carbonyl}-3-hydroxybenzoic acid::Balanol analog 22::Balanol analog 23

SMILES: CN1[C@@H]2CCC1C(NC(=O)c1ccc(O)cc1)[C@H](C2)OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(O)=O)c(O)c1

InChI Key: InChIKey=DWBQHQGWEQXPKL-CCOUQBIQSA-N

Data: 18 IC50

PDB links: 1 PDB ID contains inhibitors having a similarity of 90% to this monomer.

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 18 hits for monomerid = 3156   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Protein kinase C alpha type (Homo sapiens (Human))	BDBM3156 (2-{[2,6-dihydroxy-4-({[(3S,5R)-2-[(4-hydroxybenzen...) Show SMILES CN1[C@@H]2CCC1C(NC(=O)c1ccc(O)cc1)[C@H](C2)OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(O)=O)c(O)c1 |r,TLB:19:17:3.4:1,0:1:3.4:6.17.18,THB:7:6:3.4:1| Show InChI InChI=1S/C30H28N2O10/c1-32-16-7-10-19(32)26(31-28(38)14-5-8-17(33)9-6-14)23(13-16)42-30(41)15-11-21(35)25(22(36)12-15)27(37)24-18(29(39)40)3-2-4-20(24)34/h2-6,8-9,11-12,16,19,23,26,33-36H,7,10,13H2,1H3,(H,31,38)(H,39,40)/t16-,19?,23+,26+/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article	n/a	n/a	3.40E+4	n/a	n/a	n/a	n/a	7.5	30
Sphinx Laboratories					Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.				Bioorg Med Chem Lett 5: 2211-6 (1995) Article DOI: 10.1016/0960-894X(95)00382-4 BindingDB Entry DOI: 10.7270/Q2QR4V9M
					More data for this Ligand-Target Pair
cAMP-Dependent Protein Kinase (PKA) (Bos taurus (bovine))	BDBM3156 (2-{[2,6-dihydroxy-4-({[(3S,5R)-2-[(4-hydroxybenzen...) Show SMILES CN1[C@@H]2CCC1C(NC(=O)c1ccc(O)cc1)[C@H](C2)OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(O)=O)c(O)c1 |r,TLB:19:17:3.4:1,0:1:3.4:6.17.18,THB:7:6:3.4:1| Show InChI InChI=1S/C30H28N2O10/c1-32-16-7-10-19(32)26(31-28(38)14-5-8-17(33)9-6-14)23(13-16)42-30(41)15-11-21(35)25(22(36)12-15)27(37)24-18(29(39)40)3-2-4-20(24)34/h2-6,8-9,11-12,16,19,23,26,33-36H,7,10,13H2,1H3,(H,31,38)(H,39,40)/t16-,19?,23+,26+/m1/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article	n/a	n/a	>5.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
Sphinx Laboratories					Assay Description The activity of PKA, activated by cAMP, is measured by its ability to transfer phosphate from [gamma-32P]ATP to histone.				Bioorg Med Chem Lett 5: 2211-6 (1995) Article DOI: 10.1016/0960-894X(95)00382-4 BindingDB Entry DOI: 10.7270/Q2QR4V9M
					More data for this Ligand-Target Pair
PKC alpha and beta-2 (Homo sapiens (Human))	BDBM3156 (2-{[2,6-dihydroxy-4-({[(3S,5R)-2-[(4-hydroxybenzen...) Show SMILES CN1[C@@H]2CCC1C(NC(=O)c1ccc(O)cc1)[C@H](C2)OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(O)=O)c(O)c1 |r,TLB:19:17:3.4:1,0:1:3.4:6.17.18,THB:7:6:3.4:1| Show InChI InChI=1S/C30H28N2O10/c1-32-16-7-10-19(32)26(31-28(38)14-5-8-17(33)9-6-14)23(13-16)42-30(41)15-11-21(35)25(22(36)12-15)27(37)24-18(29(39)40)3-2-4-20(24)34/h2-6,8-9,11-12,16,19,23,26,33-36H,7,10,13H2,1H3,(H,31,38)(H,39,40)/t16-,19?,23+,26+/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article	n/a	n/a	4.40E+3	n/a	n/a	n/a	n/a	7.5	30
Sphinx Laboratories					Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.				Bioorg Med Chem Lett 5: 2211-6 (1995) Article DOI: 10.1016/0960-894X(95)00382-4 BindingDB Entry DOI: 10.7270/Q2QR4V9M
					More data for this Ligand-Target Pair
PKC alpha and beta-2 (Homo sapiens (Human))	BDBM3156 (2-{[2,6-dihydroxy-4-({[(3S,5R)-2-[(4-hydroxybenzen...) Show SMILES CN1[C@@H]2CCC1C(NC(=O)c1ccc(O)cc1)[C@H](C2)OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(O)=O)c(O)c1 |r,TLB:19:17:3.4:1,0:1:3.4:6.17.18,THB:7:6:3.4:1| Show InChI InChI=1S/C30H28N2O10/c1-32-16-7-10-19(32)26(31-28(38)14-5-8-17(33)9-6-14)23(13-16)42-30(41)15-11-21(35)25(22(36)12-15)27(37)24-18(29(39)40)3-2-4-20(24)34/h2-6,8-9,11-12,16,19,23,26,33-36H,7,10,13H2,1H3,(H,31,38)(H,39,40)/t16-,19?,23+,26+/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article	n/a	n/a	2.20E+4	n/a	n/a	n/a	n/a	7.5	30
Sphinx Laboratories					Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.				Bioorg Med Chem Lett 5: 2211-6 (1995) Article DOI: 10.1016/0960-894X(95)00382-4 BindingDB Entry DOI: 10.7270/Q2QR4V9M
					More data for this Ligand-Target Pair
PKC alpha and beta-2 (Homo sapiens (Human))	BDBM3156 (2-{[2,6-dihydroxy-4-({[(3S,5R)-2-[(4-hydroxybenzen...) Show SMILES CN1[C@@H]2CCC1C(NC(=O)c1ccc(O)cc1)[C@H](C2)OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(O)=O)c(O)c1 |r,TLB:19:17:3.4:1,0:1:3.4:6.17.18,THB:7:6:3.4:1| Show InChI InChI=1S/C30H28N2O10/c1-32-16-7-10-19(32)26(31-28(38)14-5-8-17(33)9-6-14)23(13-16)42-30(41)15-11-21(35)25(22(36)12-15)27(37)24-18(29(39)40)3-2-4-20(24)34/h2-6,8-9,11-12,16,19,23,26,33-36H,7,10,13H2,1H3,(H,31,38)(H,39,40)/t16-,19?,23+,26+/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article	n/a	n/a	1.40E+4	n/a	n/a	n/a	n/a	7.5	30
Sphinx Laboratories					Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.				Bioorg Med Chem Lett 5: 2211-6 (1995) Article DOI: 10.1016/0960-894X(95)00382-4 BindingDB Entry DOI: 10.7270/Q2QR4V9M
					More data for this Ligand-Target Pair
PKC alpha and beta-2 (Homo sapiens (Human))	BDBM3156 (2-{[2,6-dihydroxy-4-({[(3S,5R)-2-[(4-hydroxybenzen...) Show SMILES CN1[C@@H]2CCC1C(NC(=O)c1ccc(O)cc1)[C@H](C2)OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(O)=O)c(O)c1 |r,TLB:19:17:3.4:1,0:1:3.4:6.17.18,THB:7:6:3.4:1| Show InChI InChI=1S/C30H28N2O10/c1-32-16-7-10-19(32)26(31-28(38)14-5-8-17(33)9-6-14)23(13-16)42-30(41)15-11-21(35)25(22(36)12-15)27(37)24-18(29(39)40)3-2-4-20(24)34/h2-6,8-9,11-12,16,19,23,26,33-36H,7,10,13H2,1H3,(H,31,38)(H,39,40)/t16-,19?,23+,26+/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article	n/a	n/a	2.20E+4	n/a	n/a	n/a	n/a	7.5	30
Sphinx Laboratories					Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.				Bioorg Med Chem Lett 5: 2211-6 (1995) Article DOI: 10.1016/0960-894X(95)00382-4 BindingDB Entry DOI: 10.7270/Q2QR4V9M
					More data for this Ligand-Target Pair
Protein kinase C, gamma (Homo sapiens (Human))	BDBM3156 (2-{[2,6-dihydroxy-4-({[(3S,5R)-2-[(4-hydroxybenzen...) Show SMILES CN1[C@@H]2CCC1C(NC(=O)c1ccc(O)cc1)[C@H](C2)OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(O)=O)c(O)c1 |r,TLB:19:17:3.4:1,0:1:3.4:6.17.18,THB:7:6:3.4:1| Show InChI InChI=1S/C30H28N2O10/c1-32-16-7-10-19(32)26(31-28(38)14-5-8-17(33)9-6-14)23(13-16)42-30(41)15-11-21(35)25(22(36)12-15)27(37)24-18(29(39)40)3-2-4-20(24)34/h2-6,8-9,11-12,16,19,23,26,33-36H,7,10,13H2,1H3,(H,31,38)(H,39,40)/t16-,19?,23+,26+/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article	n/a	n/a	4.60E+3	n/a	n/a	n/a	n/a	n/a	n/a
Sphinx Laboratories					Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.				Bioorg Med Chem Lett 5: 2211-6 (1995) Article DOI: 10.1016/0960-894X(95)00382-4 BindingDB Entry DOI: 10.7270/Q2QR4V9M
					More data for this Ligand-Target Pair
Protein kinase C, gamma (Homo sapiens (Human))	BDBM3156 (2-{[2,6-dihydroxy-4-({[(3S,5R)-2-[(4-hydroxybenzen...) Show SMILES CN1[C@@H]2CCC1C(NC(=O)c1ccc(O)cc1)[C@H](C2)OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(O)=O)c(O)c1 |r,TLB:19:17:3.4:1,0:1:3.4:6.17.18,THB:7:6:3.4:1| Show InChI InChI=1S/C30H28N2O10/c1-32-16-7-10-19(32)26(31-28(38)14-5-8-17(33)9-6-14)23(13-16)42-30(41)15-11-21(35)25(22(36)12-15)27(37)24-18(29(39)40)3-2-4-20(24)34/h2-6,8-9,11-12,16,19,23,26,33-36H,7,10,13H2,1H3,(H,31,38)(H,39,40)/t16-,19?,23+,26+/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article	n/a	n/a	1.60E+4	n/a	n/a	n/a	n/a	n/a	n/a
Sphinx Laboratories					Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.				Bioorg Med Chem Lett 5: 2211-6 (1995) Article DOI: 10.1016/0960-894X(95)00382-4 BindingDB Entry DOI: 10.7270/Q2QR4V9M
					More data for this Ligand-Target Pair
Protein kinase C delta type (Homo sapiens (Human))	BDBM3156 (2-{[2,6-dihydroxy-4-({[(3S,5R)-2-[(4-hydroxybenzen...) Show SMILES CN1[C@@H]2CCC1C(NC(=O)c1ccc(O)cc1)[C@H](C2)OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(O)=O)c(O)c1 |r,TLB:19:17:3.4:1,0:1:3.4:6.17.18,THB:7:6:3.4:1| Show InChI InChI=1S/C30H28N2O10/c1-32-16-7-10-19(32)26(31-28(38)14-5-8-17(33)9-6-14)23(13-16)42-30(41)15-11-21(35)25(22(36)12-15)27(37)24-18(29(39)40)3-2-4-20(24)34/h2-6,8-9,11-12,16,19,23,26,33-36H,7,10,13H2,1H3,(H,31,38)(H,39,40)/t16-,19?,23+,26+/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article	n/a	n/a	5.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
Sphinx Laboratories					Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.				Bioorg Med Chem Lett 5: 2211-6 (1995) Article DOI: 10.1016/0960-894X(95)00382-4 BindingDB Entry DOI: 10.7270/Q2QR4V9M
					More data for this Ligand-Target Pair
Protein kinase C delta type (Homo sapiens (Human))	BDBM3156 (2-{[2,6-dihydroxy-4-({[(3S,5R)-2-[(4-hydroxybenzen...) Show SMILES CN1[C@@H]2CCC1C(NC(=O)c1ccc(O)cc1)[C@H](C2)OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(O)=O)c(O)c1 |r,TLB:19:17:3.4:1,0:1:3.4:6.17.18,THB:7:6:3.4:1| Show InChI InChI=1S/C30H28N2O10/c1-32-16-7-10-19(32)26(31-28(38)14-5-8-17(33)9-6-14)23(13-16)42-30(41)15-11-21(35)25(22(36)12-15)27(37)24-18(29(39)40)3-2-4-20(24)34/h2-6,8-9,11-12,16,19,23,26,33-36H,7,10,13H2,1H3,(H,31,38)(H,39,40)/t16-,19?,23+,26+/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article	n/a	n/a	3.80E+3	n/a	n/a	n/a	n/a	n/a	n/a
Sphinx Laboratories					Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.				Bioorg Med Chem Lett 5: 2211-6 (1995) Article DOI: 10.1016/0960-894X(95)00382-4 BindingDB Entry DOI: 10.7270/Q2QR4V9M
					More data for this Ligand-Target Pair
Protein kinase C, epsilon (Homo sapiens (Human))	BDBM3156 (2-{[2,6-dihydroxy-4-({[(3S,5R)-2-[(4-hydroxybenzen...) Show SMILES CN1[C@@H]2CCC1C(NC(=O)c1ccc(O)cc1)[C@H](C2)OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(O)=O)c(O)c1 |r,TLB:19:17:3.4:1,0:1:3.4:6.17.18,THB:7:6:3.4:1| Show InChI InChI=1S/C30H28N2O10/c1-32-16-7-10-19(32)26(31-28(38)14-5-8-17(33)9-6-14)23(13-16)42-30(41)15-11-21(35)25(22(36)12-15)27(37)24-18(29(39)40)3-2-4-20(24)34/h2-6,8-9,11-12,16,19,23,26,33-36H,7,10,13H2,1H3,(H,31,38)(H,39,40)/t16-,19?,23+,26+/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article	n/a	n/a	2.70E+4	n/a	n/a	n/a	n/a	n/a	n/a
Sphinx Laboratories					Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.				Bioorg Med Chem Lett 5: 2211-6 (1995) Article DOI: 10.1016/0960-894X(95)00382-4 BindingDB Entry DOI: 10.7270/Q2QR4V9M
					More data for this Ligand-Target Pair
Protein kinase C, epsilon (Homo sapiens (Human))	BDBM3156 (2-{[2,6-dihydroxy-4-({[(3S,5R)-2-[(4-hydroxybenzen...) Show SMILES CN1[C@@H]2CCC1C(NC(=O)c1ccc(O)cc1)[C@H](C2)OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(O)=O)c(O)c1 |r,TLB:19:17:3.4:1,0:1:3.4:6.17.18,THB:7:6:3.4:1| Show InChI InChI=1S/C30H28N2O10/c1-32-16-7-10-19(32)26(31-28(38)14-5-8-17(33)9-6-14)23(13-16)42-30(41)15-11-21(35)25(22(36)12-15)27(37)24-18(29(39)40)3-2-4-20(24)34/h2-6,8-9,11-12,16,19,23,26,33-36H,7,10,13H2,1H3,(H,31,38)(H,39,40)/t16-,19?,23+,26+/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article	n/a	n/a	4.90E+4	n/a	n/a	n/a	n/a	n/a	n/a
Sphinx Laboratories					Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.				Bioorg Med Chem Lett 5: 2211-6 (1995) Article DOI: 10.1016/0960-894X(95)00382-4 BindingDB Entry DOI: 10.7270/Q2QR4V9M
					More data for this Ligand-Target Pair
Protein kinase C, eta (Homo sapiens (Human))	BDBM3156 (2-{[2,6-dihydroxy-4-({[(3S,5R)-2-[(4-hydroxybenzen...) Show SMILES CN1[C@@H]2CCC1C(NC(=O)c1ccc(O)cc1)[C@H](C2)OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(O)=O)c(O)c1 |r,TLB:19:17:3.4:1,0:1:3.4:6.17.18,THB:7:6:3.4:1| Show InChI InChI=1S/C30H28N2O10/c1-32-16-7-10-19(32)26(31-28(38)14-5-8-17(33)9-6-14)23(13-16)42-30(41)15-11-21(35)25(22(36)12-15)27(37)24-18(29(39)40)3-2-4-20(24)34/h2-6,8-9,11-12,16,19,23,26,33-36H,7,10,13H2,1H3,(H,31,38)(H,39,40)/t16-,19?,23+,26+/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article	n/a	n/a	2.80E+3	n/a	n/a	n/a	n/a	n/a	n/a
Sphinx Laboratories					Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.				Bioorg Med Chem Lett 5: 2211-6 (1995) Article DOI: 10.1016/0960-894X(95)00382-4 BindingDB Entry DOI: 10.7270/Q2QR4V9M
					More data for this Ligand-Target Pair
Protein kinase C, eta (Homo sapiens (Human))	BDBM3156 (2-{[2,6-dihydroxy-4-({[(3S,5R)-2-[(4-hydroxybenzen...) Show SMILES CN1[C@@H]2CCC1C(NC(=O)c1ccc(O)cc1)[C@H](C2)OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(O)=O)c(O)c1 |r,TLB:19:17:3.4:1,0:1:3.4:6.17.18,THB:7:6:3.4:1| Show InChI InChI=1S/C30H28N2O10/c1-32-16-7-10-19(32)26(31-28(38)14-5-8-17(33)9-6-14)23(13-16)42-30(41)15-11-21(35)25(22(36)12-15)27(37)24-18(29(39)40)3-2-4-20(24)34/h2-6,8-9,11-12,16,19,23,26,33-36H,7,10,13H2,1H3,(H,31,38)(H,39,40)/t16-,19?,23+,26+/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article	n/a	n/a	2.50E+3	n/a	n/a	n/a	n/a	n/a	n/a
Sphinx Laboratories					Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.				Bioorg Med Chem Lett 5: 2211-6 (1995) Article DOI: 10.1016/0960-894X(95)00382-4 BindingDB Entry DOI: 10.7270/Q2QR4V9M
					More data for this Ligand-Target Pair
Protein kinase C (PKC) (Homo sapiens (Human))	BDBM3156 (2-{[2,6-dihydroxy-4-({[(3S,5R)-2-[(4-hydroxybenzen...) Show SMILES CN1[C@@H]2CCC1C(NC(=O)c1ccc(O)cc1)[C@H](C2)OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(O)=O)c(O)c1 |r,TLB:19:17:3.4:1,0:1:3.4:6.17.18,THB:7:6:3.4:1| Show InChI InChI=1S/C30H28N2O10/c1-32-16-7-10-19(32)26(31-28(38)14-5-8-17(33)9-6-14)23(13-16)42-30(41)15-11-21(35)25(22(36)12-15)27(37)24-18(29(39)40)3-2-4-20(24)34/h2-6,8-9,11-12,16,19,23,26,33-36H,7,10,13H2,1H3,(H,31,38)(H,39,40)/t16-,19?,23+,26+/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article	n/a	n/a	>5.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
Sphinx Laboratories					Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.				Bioorg Med Chem Lett 5: 2211-6 (1995) Article DOI: 10.1016/0960-894X(95)00382-4 BindingDB Entry DOI: 10.7270/Q2QR4V9M
					More data for this Ligand-Target Pair
Protein kinase C (PKC) (Homo sapiens (Human))	BDBM3156 (2-{[2,6-dihydroxy-4-({[(3S,5R)-2-[(4-hydroxybenzen...) Show SMILES CN1[C@@H]2CCC1C(NC(=O)c1ccc(O)cc1)[C@H](C2)OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(O)=O)c(O)c1 |r,TLB:19:17:3.4:1,0:1:3.4:6.17.18,THB:7:6:3.4:1| Show InChI InChI=1S/C30H28N2O10/c1-32-16-7-10-19(32)26(31-28(38)14-5-8-17(33)9-6-14)23(13-16)42-30(41)15-11-21(35)25(22(36)12-15)27(37)24-18(29(39)40)3-2-4-20(24)34/h2-6,8-9,11-12,16,19,23,26,33-36H,7,10,13H2,1H3,(H,31,38)(H,39,40)/t16-,19?,23+,26+/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article	n/a	n/a	>5.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
Sphinx Laboratories					Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.				Bioorg Med Chem Lett 5: 2211-6 (1995) Article DOI: 10.1016/0960-894X(95)00382-4 BindingDB Entry DOI: 10.7270/Q2QR4V9M
					More data for this Ligand-Target Pair
cAMP-Dependent Protein Kinase (PKA) (Bos taurus (bovine))	BDBM3156 (2-{[2,6-dihydroxy-4-({[(3S,5R)-2-[(4-hydroxybenzen...) Show SMILES CN1[C@@H]2CCC1C(NC(=O)c1ccc(O)cc1)[C@H](C2)OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(O)=O)c(O)c1 |r,TLB:19:17:3.4:1,0:1:3.4:6.17.18,THB:7:6:3.4:1| Show InChI InChI=1S/C30H28N2O10/c1-32-16-7-10-19(32)26(31-28(38)14-5-8-17(33)9-6-14)23(13-16)42-30(41)15-11-21(35)25(22(36)12-15)27(37)24-18(29(39)40)3-2-4-20(24)34/h2-6,8-9,11-12,16,19,23,26,33-36H,7,10,13H2,1H3,(H,31,38)(H,39,40)/t16-,19?,23+,26+/m1/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article	n/a	n/a	>5.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
Sphinx Laboratories					Assay Description The activity of PKA, activated by cAMP, is measured by its ability to transfer phosphate from [gamma-32P]ATP to histone.				Bioorg Med Chem Lett 5: 2211-6 (1995) Article DOI: 10.1016/0960-894X(95)00382-4 BindingDB Entry DOI: 10.7270/Q2QR4V9M
					More data for this Ligand-Target Pair
Protein kinase C alpha type (Homo sapiens (Human))	BDBM3156 (2-{[2,6-dihydroxy-4-({[(3S,5R)-2-[(4-hydroxybenzen...) Show SMILES CN1[C@@H]2CCC1C(NC(=O)c1ccc(O)cc1)[C@H](C2)OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(O)=O)c(O)c1 |r,TLB:19:17:3.4:1,0:1:3.4:6.17.18,THB:7:6:3.4:1| Show InChI InChI=1S/C30H28N2O10/c1-32-16-7-10-19(32)26(31-28(38)14-5-8-17(33)9-6-14)23(13-16)42-30(41)15-11-21(35)25(22(36)12-15)27(37)24-18(29(39)40)3-2-4-20(24)34/h2-6,8-9,11-12,16,19,23,26,33-36H,7,10,13H2,1H3,(H,31,38)(H,39,40)/t16-,19?,23+,26+/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article	n/a	n/a	3.50E+4	n/a	n/a	n/a	n/a	7.5	30
Sphinx Laboratories					Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.				Bioorg Med Chem Lett 5: 2211-6 (1995) Article DOI: 10.1016/0960-894X(95)00382-4 BindingDB Entry DOI: 10.7270/Q2QR4V9M
					More data for this Ligand-Target Pair